SNGX / Soligenix, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Soligenix, Inc.

Jumlah Saham Beredar 4,285,570 shares
Saham Orang Dalam5,117,068 shares
Orang Dalam Sejati32
Skor Sentimen Orang Dalam

Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.

Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan akumulasi orang dalam tertinggi.

Skor Sentimen Petugas

Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.

Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.

Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan sentimen orang dalam tertinggi.

Metrik Utama Orang Dalam

Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.

Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).

Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)

0 ( )

9648 out of 11305

Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).

Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)

0.000 %( )

9563 out of 11224

Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.

Grafik Perdagangan Orang Dalam

Grafik berikut menunjukkan Soligenix, Inc. transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.

Daftar Orang Dalam dan Metrik Profitabilitas

Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.

See our leaderboard of most profitable insider traders.

Orang Dalam Rata-rata Keuntungan (%) Saham
Dimiliki
Terbagi
Disesuaikan
Robert N Brey 10,000
Keith L Brownlie Director - [D] 50,000 3,659
Marco Maria Brughera Director - [D] 2,750 177
Cyrille F Buhrman Director - [D] 4,900,020 4,900,020
Paolo Cavazza - 293,510 18,936
Enrico Cavazza - 293,510 18,936
Francesca Cavazza - 293,510 18,936
Preta Martina Cavazza - 293,510 18,936
Silvia Cavazza - 293,510 18,936
Cote Timothy R. Director - [D] 50,634 3,165
Orang Dalam Rata-rata Keuntungan (%) Saham
Dimiliki
Terbagi
Disesuaikan
Oreola Donini 70,000
Corp Plc Elan 10% Owner - [10%] 162,600 162,600
Elan International Services Ltd 10% Owner - [10%] 162,600 162,600
Elan Pharmaceutical Investments Ii Ltd 10% Owner - [10%] 1,468,900 1,468,900
Elan Pharmaceutical Investments Ltd 10% Owner - [10%] 162,600 162,600
SPA Essetifin - 293,510 18,936
Guarino Jonathan L. Senior Vice President and CFO - [O] 10,000 645
Kevin Horgan 85,000
Corp Intrexon 10% Owner - [10%] 85,397 5,509
Randal J Kirk 10% Owner - [10%] 85,397 5,509
Karen R Krumeich SVP and CFO - [O] 26,000 1,902
Orang Dalam Rata-rata Keuntungan (%) Saham
Dimiliki
Terbagi
Disesuaikan
Anthony Gregg Lapointe Director - [D] 73,781 5,399
Leadiant Biosciences, Inc. 10% Owner - [10%] 293,510 18,936
Parks Diane L. Director - [D] 14,940 964
Pearson Mark E. Director, 10% Owner - [D] [10%] 78,338 5,054
Rubin Robert J. Director - [D] 4,385 283
Christopher J Schaber CHAIRMAN, CEO AND PRESIDENT, Director - [D] [O] 90,095 5,813
Sigma Tau International Sa 10% Owner - [10%] 2,711,393 3,967,889
Sigma-Tau America S.A. 10% Owner - [10%] 2,711,393 3,967,889
Richard Straube SENIOR VICE PRESIDENT AND CMO - [O] 8,000 516
Joseph Michael Warusz VP of Finance/Acting CFO - [O] 12,955 948
Jerome B Zeldis Director - [D] 22,917 1,479

Report errors via our new Insider Auditing Tool

Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di SNGX / Soligenix, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2022-05-18 Straube Richard 8,000 0.5000 516 7.7500 4,000 76 225.14 112,172 2,804.31
2022-05-18 SCHABER CHRISTOPHER J 20,000 0.4433 1,290 6.8712 8,866
2021-12-17 SCHABER CHRISTOPHER J 7,000 0.7399 452 11.4684 5,179
2021-12-15 Guarino Jonathan L. 1,000 0.7000 65 10.8500 700
2021-12-14 Guarino Jonathan L. 10,000 0.7119 645 11.0344 7,119
2021-12-14 SCHABER CHRISTOPHER J 10,000 0.7269 645 11.2670 7,269
2021-05-14 ZELDIS JEROME B 3,000 0.8880 194 13.7640 2,664
2019-11-19 ZELDIS JEROME B 2,000 0.9250 129 14.3375 1,850
2019-11-19 SCHABER CHRISTOPHER J 10,770 0.9300 695 14.4150 10,016

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

SNGX / Soligenix, Inc. Insider Trades
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek

Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di SNGX / Soligenix, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
2021-05-14 ZELDIS JEROME B 3,000 0.9002 194 13.9531 2,701 17 1.02 -2,503 -92.71
2017-11-29 Essetifin SPA 16,416 2.1200 1,059 32.8600 34,802
2017-11-29 Essetifin SPA 5,954 2.1200 384 32.8600 12,622
2017-11-29 Essetifin SPA 271,140 2.1200 17,493 32.8600 574,817
2017-05-08 KIRK RANDAL J 1,881 2.5400 121 39.3700 4,778
2017-05-08 KIRK RANDAL J 9,695 2.5400 625 39.3700 24,625
2017-05-05 KIRK RANDAL J 13,893 2.7000 896 41.8500 37,511
2017-05-05 KIRK RANDAL J 71,607 2.7000 4,620 41.8500 193,339
2017-05-04 KIRK RANDAL J 2,278 2.9700 147 46.0350 6,766

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

SNGX / Soligenix, Inc. Insider Trades
Riwayat Transaksi

Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.

Berkas
Tanggal
Perdagangan
Tanggal
Formulir Orang Dalam Ticker Judul Keamanan Kode 10b5-1 Langsung Latihan
Harga
Satuan
Harga
Unit
Diubah
Nilai
Diubah (1 ribu)
Sisa
Pilihan
Sisa
Saham
2023-05-05 3 Cote Timothy R. Silk Road Therapeutics, Inc. SNGX Common Stock I 25,317
2022-05-18 2022-05-18 4 Straube Richard SNGX COMMON STOCK P - Purchase D 0.5000 8,000 4 8,000
2022-05-18 2022-05-18 4 SCHABER CHRISTOPHER J SNGX Common Stock P - Purchase D 0.4433 20,000 9 90,095
2022-01-21 2022-01-21 4 Guarino Jonathan L. SNGX Option (Right to Buy) A - Award D 0.78 50,000 50,000
2022-01-21 2022-01-21 4 SCHABER CHRISTOPHER J SNGX Option (Right to Buy) A - Award D 0.69 47,315 47,315
2022-01-04 2022-01-03 4 SCHABER CHRISTOPHER J SNGX Option (Right to Buy) A - Award D 0.69 60,000 60,000
2021-12-20 2021-12-17 4 SCHABER CHRISTOPHER J SNGX COMMON STOCK P - Purchase D 0.7399 7,000 5 70,095
2021-12-15 2021-12-15 4 Guarino Jonathan L. SNGX COMMON STOCK P - Purchase D 0.7000 1,000 1 11,000
2021-12-15 2021-12-14 4 Guarino Jonathan L. SNGX COMMON STOCK P - Purchase D 0.7119 10,000 7 10,000
2021-12-14 2021-12-14 4 SCHABER CHRISTOPHER J SNGX COMMON STOCK P - Purchase D 0.7269 10,000 7 63,095
2021-12-10 2021-12-09 4 SCHABER CHRISTOPHER J SNGX Option (Right to Buy) A - Award D 0.78 60,000 60,000
2021-12-10 2021-12-09 4 Guarino Jonathan L. SNGX Stock Option (Right to Buy) A - Award D 0.78 50,000 50,000
2021-12-10 2021-12-09 4 Donini Oreola SNGX Option (Right to Buy) A - Award D 0.78 70,000 70,000
2021-12-10 2021-12-09 4 Straube Richard SNGX Option (Right to Buy) A - Award D 0.78 40,000 40,000
2021-09-24 2021-09-23 4 Parks Diane L. SNGX Stock Option (Right to Buy) A - Award D 1.03 29,126 29,126
2021-09-24 2021-09-23 4 ZELDIS JEROME B SNGX Stock Option (Right to Buy) A - Award D 1.03 29,126 29,126
2021-09-24 2021-09-23 4 LAPOINTE ANTHONY GREGG SNGX Stock Option (Right to Buy) A - Award D 1.03 29,126 29,126
2021-09-24 2021-09-23 4 RUBIN ROBERT J. SNGX Stock Option (Right to Buy) A - Award D 1.03 29,126 29,126
2021-05-18 2021-05-14 4 ZELDIS JEROME B SNGX Common Stock S - Sale D 0.9002 -3,000 -3 22,917
2021-05-18 2021-05-14 4 ZELDIS JEROME B SNGX Common Stock P - Purchase D 0.8880 3,000 3 25,917
2021-01-04 2021-01-04 4 SCHABER CHRISTOPHER J SNGX Option (Right to Buy) A - Award D 1.28 60,000 60,000
2020-12-11 2020-12-10 4 Donini Oreola SNGX Option (Right to Buy) A - Award D 2.34 70,000 70,000
2020-12-11 2020-12-10 4 SCHABER CHRISTOPHER J SNGX Option (Right to Buy) A - Award D 2.34 60,000 60,000
2020-12-11 2020-12-10 4 Straube Richard SNGX Option (Right to Buy) A - Award D 2.34 40,000 40,000
2020-12-11 2020-12-10 4 Guarino Jonathan L. SNGX Stock Option (Right to Buy) A - Award D 2.34 40,000 40,000
2020-09-18 2020-09-16 4 LAPOINTE ANTHONY GREGG SNGX Stock Option (Right to Buy) A - Award D 1.97 15,228 15,228
2020-09-18 2020-09-16 4 ZELDIS JEROME B SNGX Stock Option (Right to Buy) A - Award D 1.97 15,228 15,228
2020-09-18 2020-09-16 4 RUBIN ROBERT J. SNGX Stock Option (Right to Buy) A - Award D 1.97 15,228 15,228
2020-09-18 2020-09-16 4 Parks Diane L. SNGX Stock Option (Right to Buy) A - Award D 1.97 15,228 15,228
2020-06-19 2020-06-18 4 Parks Diane L. SNGX Stock Option (Right to Buy) A - Award D 1.76 13,500 13,500
2020-01-02 2020-01-02 4 SCHABER CHRISTOPHER J SNGX Option (Right to Buy) A - Award D 1.45 60,000 60,000
2019-12-13 2019-12-12 4 Donini Oreola SNGX Option (Right to Buy) A - Award D 1.24 60,000 60,000
2019-12-13 2019-12-12 4 Guarino Jonathan L. SNGX Stock Option (Right to Buy) A - Award D 1.24 10,000 10,000
2019-12-13 2019-12-12 4 SCHABER CHRISTOPHER J SNGX Option (Right to Buy) A - Award D 1.24 60,000 60,000
2019-12-13 2019-12-12 4 Straube Richard SNGX Option (Right to Buy) A - Award D 1.24 30,000 30,000
2019-11-19 2019-11-19 4 SCHABER CHRISTOPHER J SNGX Common Stock P - Purchase D 0.9300 10,770 10 53,095
2019-11-19 2019-11-19 4 ZELDIS JEROME B SNGX Common Stock P - Purchase D 0.9250 2,000 2 22,917
2019-09-23 2019-09-23 4 Parks Diane L. SNGX Common Stock P - Purchase D 0.9284 14,940 14 14,940
2019-09-23 2019-09-19 4 ZELDIS JEROME B SNGX Common Stock P - Purchase D 0.9350 4,000 4 20,917
2019-09-11 2019-09-09 4 Guarino Jonathan L. SNGX Stock Option (Right to Buy) A - Award D 0.97 40,000 40,000
2019-09-10 2019-09-06 4 LAPOINTE ANTHONY GREGG SNGX Stock Option (Right to Buy) A - Award D 0.97 30,928 30,928
2019-09-10 2019-09-06 4 Parks Diane L. SNGX Stock Option (Right to Buy) A - Award D 0.97 30,928 30,928
2019-09-10 2019-09-06 4 Pearson Mark E. SNGX Stock Option (Right to Buy) A - Award D 0.97 30,928 30,928
2019-09-10 2019-09-06 4 RUBIN ROBERT J. SNGX Stock Option (Right to Buy) A - Award D 0.97 30,928 30,928
2019-09-10 2019-09-06 4 ZELDIS JEROME B SNGX Stock Option (Right to Buy) A - Award D 0.97 30,928 30,928
2019-07-10 2019-06-28 4 Pearson Mark E. SNGX Common Stock A - Award I 0.7100 78,338 56 78,338
2019-07-08 2019-07-08 4 Parks Diane L. SNGX Stock Option (Right to Buy) A - Award D 0.86 1,500 1,500
2019-04-22 2019-04-22 4 SCHABER CHRISTOPHER J SNGX Common Stock P - Purchase D 0.7154 5,000 4 42,325
2019-04-22 2019-04-22 4 ZELDIS JEROME B SNGX Common Stock P - Purchase D 0.7274 10,000 7 16,917
2019-01-04 2019-01-02 4 SCHABER CHRISTOPHER J SNGX Option (Right to Buy) A - Award D 0.96 60,000 60,000
2018-12-14 2018-12-13 4 Donini Oreola SNGX Option (Right to Buy) A - Award D 0.97 40,000 40,000
2018-12-14 2018-12-13 4 Krumeich Karen R SNGX Option (Right to Buy) A - Award D 0.97 40,000 40,000
2018-12-14 2018-12-13 4 SCHABER CHRISTOPHER J SNGX Option (Right to Buy) A - Award D 0.97 60,000 60,000
2018-12-14 2018-12-13 4 Straube Richard SNGX Option (Right to Buy) A - Award D 0.97 40,000 40,000
2018-10-18 2018-10-18 4 SCHABER CHRISTOPHER J SNGX Common Stock P - Purchase D 1.1698 8,700 10 37,325
2018-10-17 2018-10-17 4 Pearson Mark E. SNGX Common Stock P - Purchase D 1.1600 170,000 197 2,500,000
2018-09-28 2018-09-27 4 Brownlie Keith L SNGX Stock Option (Right to Buy) A - Award D 1.67 17,964 17,964
2018-09-28 2018-09-27 4 LAPOINTE ANTHONY GREGG SNGX Stock Option (Right to Buy) A - Award D 1.67 17,964 17,964
2018-09-28 2018-09-27 4 Pearson Mark E. SNGX Stock Option (Right to Buy) A - Award D 1.67 17,964 17,964
2018-09-28 2018-09-27 4 RUBIN ROBERT J. SNGX Stock Option (Right to Buy) A - Award D 1.67 17,964 17,964
2018-09-28 2018-09-27 4 ZELDIS JEROME B SNGX Stock Option (Right to Buy) A - Award D 1.67 17,964 17,964
2018-08-22 2018-08-22 4 SCHABER CHRISTOPHER J SNGX Common Stock P - Purchase D 1.4198 3,530 5 28,625
2018-07-25 3 Pearson Mark E. SNGX COMMON STOCK D 4,660,000
2018-07-25 3 Pearson Mark E. SNGX COMMON STOCK D 4,660,000
2018-07-25 3 Pearson Mark E. SNGX COMMON STOCK D 4,660,000
2018-07-25 2018-07-20 4 Pearson Mark E. SNGX Stock Option (Right to Buy) A - Award D 1.22 1,500 1,500
2017-12-11 2017-12-07 4 Donini Oreola SNGX Option (Right to Buy) A - Award D 2.01 35,000 35,000
2017-12-11 2017-12-07 4 Krumeich Karen R SNGX Option (Right to Buy) A - Award D 2.01 35,000 35,000
2017-12-11 2017-12-07 4 SCHABER CHRISTOPHER J SNGX Option (Right to Buy) A - Award D 2.01 80,000 80,000
2017-12-11 2017-12-07 4 Straube Richard SNGX Option (Right to Buy) A - Award D 2.01 35,000 35,000
2017-12-01 2017-11-29 4 Essetifin SPA SNGX Common Stock P - Purchase D 2.1200 16,416 35 293,510
2017-12-01 2017-11-29 4 Essetifin SPA Indirect SNGX Common Stock S - Sale I 2.1200 -16,416 -35 0
2017-12-01 2017-11-29 4 Essetifin SPA SNGX Common Stock P - Purchase D 2.1200 5,954 13 277,094
2017-12-01 2017-11-29 4 Essetifin SPA Indirect SNGX Common Stock S - Sale I 2.1200 -5,954 -13 0
2017-12-01 2017-11-29 4 Essetifin SPA SNGX Common Stock P - Purchase D 2.1200 271,140 575 271,140
2017-12-01 2017-11-29 4 Essetifin SPA Indirect SNGX Common Stock S - Sale I 2.1200 -271,140 -575 0
2017-06-12 2017-06-08 4 ZELDIS JEROME B SNGX Stock Option (Right to Buy) A - Award D 2.29 13,100 13,100
2017-06-12 2017-06-08 4 RUBIN ROBERT J. SNGX Stock Option (Right to Buy) A - Award D 2.29 13,100 13,100
2017-06-12 2017-06-08 4 LAPOINTE ANTHONY GREGG SNGX Stock Option (Right to Buy) A - Award D 2.29 13,100 13,100
2017-06-12 2017-06-08 4 Brughera Marco Maria SNGX Stock Option (Right to Buy) A - Award D 2.29 13,100 13,100
2017-06-12 2017-06-08 4 Brownlie Keith L SNGX Stock Option (Right to Buy) A - Award D 2.29 13,100 13,100
2017-05-08 2017-05-08 4 KIRK RANDAL J by Intrexon SNGX Common Stock S - Sale I 2.5400 -1,881 -5 85,397
2017-05-08 2017-05-08 4 KIRK RANDAL J by NRM VII Holdings SNGX Common Stock S - Sale I 2.5400 -9,695 -25 440,418
2017-05-08 2017-05-05 4 KIRK RANDAL J by Intrexon SNGX Common Stock S - Sale I 2.7000 -13,893 -38 87,278
2017-05-08 2017-05-05 4 KIRK RANDAL J by NRM VII Holdings SNGX Common Stock S - Sale I 2.7000 -71,607 -193 450,113
2017-05-08 2017-05-04 4 KIRK RANDAL J by NRM VII Holdings SNGX Warrant to Purchase Common Stock X - Other I 0.80 -250,000 0
2017-05-08 2017-05-04 4 KIRK RANDAL J by Intrexon SNGX Common Stock S - Sale I 2.9700 -2,278 -7 101,171
2017-05-08 2017-05-04 4 KIRK RANDAL J by NRM VII Holdings SNGX Common Stock S - Sale I 2.9700 -11,739 -35 521,720
2017-05-08 2017-05-04 4 KIRK RANDAL J by NRM VII Holdings SNGX Common Stock S - Sale I 4.0100 -49,875 -200 533,459
2017-05-08 2017-05-04 4 KIRK RANDAL J by NRM VII Holdings SNGX Common Stock X - Other I 0.8000 250,000 200 583,334
2017-04-04 2017-03-31 4 Donini Oreola SNGX Option (Right to Buy) A - Award D 2.67 20,000 20,000
2017-04-04 2017-03-31 4 Krumeich Karen R SNGX Option (Right to Buy) A - Award D 2.67 20,000 20,000
2017-04-04 2017-03-31 4 SCHABER CHRISTOPHER J SNGX Option (Right to Buy) A - Award D 2.67 50,000 50,000
2017-04-04 2017-03-31 4 Straube Richard SNGX Option (Right to Buy) A - Award D 2.67 20,000 20,000
2016-12-20 2016-12-16 4 Brughera Marco Maria SNGX Common Stock Warrant P - Purchase D 3.95 0.0001 2,500 0 2,500
2016-12-20 2016-12-16 4 Brughera Marco Maria SNGX Common Stock P - Purchase D 3.1599 2,000 6 2,750
2016-12-20 2016-12-16 4 RUBIN ROBERT J. SNGX Common Stock Warrant P - Purchase D 3.95 0.0001 3,956 0 3,956
2016-12-20 2016-12-16 4 RUBIN ROBERT J. SNGX Common Stock P - Purchase D 3.1599 3,165 10 4,385
2016-12-20 2016-12-16 4 SCHABER CHRISTOPHER J SNGX Common Stock Warrant P - Purchase D 3.95 0.0001 19,755 0 19,755
2016-12-20 2016-12-16 4 SCHABER CHRISTOPHER J SNGX Common Stock P - Purchase D 3.1599 15,804 50 25,095
2016-06-22 3 Krumeich Karen R SNGX Common Stock D 26,000
2016-06-22 3 Krumeich Karen R SNGX Common Stock D 26,000
2016-06-22 2016-06-16 4 Krumeich Karen R SNGX Option (Right to Buy) A - Award D 0.74 100,000 100,000
2016-06-20 2016-06-16 4 RUBIN ROBERT J. SNGX Stock Option (Right to Buy) A - Award D 0.74 40,541 40,541
2016-06-20 2016-06-16 4 ZELDIS JEROME B SNGX Stock Option (Right to Buy) A - Award D 0.74 40,541 40,541
2016-06-20 2016-06-16 4 LAPOINTE ANTHONY GREGG SNGX Stock Option (Right to Buy) A - Award D 0.74 40,541 40,541
2016-06-20 2016-06-16 4 Brughera Marco Maria SNGX Stock Option (Right to Buy) A - Award D 0.74 40,541 40,541
2016-06-20 2016-06-16 4 Brownlie Keith L SNGX Stock Option (Right to Buy) A - Award D 0.74 40,541 40,541
2016-01-04 2015-12-31 4 Donini Oreola SNGX Stock Option (Right to Buy) A - Award D 1.13 70,000 70,000
2016-01-04 2015-12-31 4 Straube Richard SNGX Stock Option (Right to Buy) A - Award D 1.13 70,000 70,000
2016-01-04 2015-12-31 4 Warusz Joseph Michael SNGX Option (Right to Buy) A - Award D 1.13 55,000 55,000
2016-01-04 2015-12-31 4 SCHABER CHRISTOPHER J SNGX Option (Right to Buy) A - Award D 1.13 140,000 140,000
2015-12-23 2015-12-23 4 ZELDIS JEROME B SNGX Common Stock P - Purchase D 1.2700 2,500 3 69,166
2015-12-23 2015-12-22 4 SCHABER CHRISTOPHER J SNGX Common Stock P - Purchase D 1.2878 10,000 13 85,761
2015-08-31 2015-08-31 4 LAPOINTE ANTHONY GREGG SNGX Common Stock Warrant M - Exercise D 0.30 -25,000 0
2015-08-31 2015-08-31 4 LAPOINTE ANTHONY GREGG SNGX Common Stock M - Exercise D 0.3000 25,000 8 73,781
2015-07-01 2015-07-01 4 SCHABER CHRISTOPHER J SNGX Common Stock Warrant M - Exercise D 0.61 -7,143 0
2015-07-01 2015-07-01 4 SCHABER CHRISTOPHER J SNGX Common Stock M - Exercise D 0.6100 7,143 4 82,904
2015-06-19 2015-06-18 4 ZELDIS JEROME B SNGX Stock Option (Right to Buy) A - Award D 1.51 19,868 19,868
2015-06-19 2015-06-18 4 RUBIN ROBERT J. SNGX Stock Option (Right to Buy) A - Award D 1.51 19,868 19,868
2015-06-19 2015-06-18 4 Brughera Marco Maria SNGX Stock Option (Right to Buy) A - Award D 1.51 19,868 19,868
2015-06-19 2015-06-18 4 Brownlie Keith L SNGX Stock Option (Right to Buy) A - Award D 1.51 19,868 19,868
2015-06-19 2015-06-18 4 LAPOINTE ANTHONY GREGG SNGX Stock Option (Right to Buy) A - Award D 1.51 19,868 19,868
2015-04-09 2015-04-09 4 Brownlie Keith L SNGX Common Stock Warrant M - Exercise D 0.61 -14,286 0
2015-04-09 2015-04-09 4 Brownlie Keith L SNGX Common Stock M - Exercise D 0.6100 14,286 9 50,000
2015-04-09 2015-04-09 4 ZELDIS JEROME B SNGX Common Stock Warrant M - Exercise D 0.61 -17,857 0
2015-04-09 2015-04-09 4 ZELDIS JEROME B SNGX Common Stock M - Exercise D 0.6100 17,857 11 66,666
2014-12-24 2014-12-24 4 Warusz Joseph Michael SNGX Common Stock Warrant P - Purchase D 1.48 4,959 4,959
2014-12-24 2014-12-22 4 Warusz Joseph Michael SNGX Common Stock P - Purchase D 1.2100 8,265 10 12,955
2014-12-24 2014-12-24 4 SCHABER CHRISTOPHER J SNGX Common Stock Warrant P - Purchase D 1.48 4,959 4,959
2014-12-24 2014-12-22 4 SCHABER CHRISTOPHER J SNGX Common Stock P - Purchase D 1.2100 8,265 10 75,761
2014-12-08 2014-12-04 4 Warusz Joseph Michael SNGX Option (Right to Buy) A - Award D 1.50 45,000 45,000
2014-12-08 2014-12-04 4 Straube Richard SNGX Stock Option (Right to Buy) A - Award D 1.50 50,000 50,000
2014-12-08 2014-12-04 4 SCHABER CHRISTOPHER J SNGX Option (Right to Buy) A - Award D 1.50 100,000 100,000
2014-08-05 2014-08-05 4 Brughera Marco Maria SNGX Stock Option (Right to Buy) M - Exercise D 2.01 -7,500 7,500
2014-08-05 2014-08-05 4 Brughera Marco Maria SNGX Common Stock M - Exercise D 2.0100 7,500 15 7,500
2014-06-20 2014-06-19 4 RUBIN ROBERT J. SNGX Stock Option (Right to Buy) A - Award D 2.19 13,669 13,669
2014-06-20 2014-06-19 4 ZELDIS JEROME B SNGX Stock Option (Right to Buy) A - Award D 2.19 13,669 13,669
2014-06-20 2014-06-19 4 Brownlie Keith L SNGX Stock Option (Right to Buy) A - Award D 2.19 13,669 13,669
2014-06-20 2014-06-19 4 Brughera Marco Maria SNGX Stock Option (Right to Buy) A - Award D 2.19 13,669 13,669
2014-06-20 2014-06-19 4 LAPOINTE ANTHONY GREGG SNGX Stock Option (Right to Buy) A - Award D 2.19 13,669 13,669
2014-05-19 2014-05-19 4 Warusz Joseph Michael SNGX Option (Right to Buy) M - Exercise D 0.64 -4,690 25,310
2014-05-19 2014-05-19 4 Warusz Joseph Michael SNGX Common Stock M - Exercise D 0.6400 4,690 3 4,690
2014-05-16 2014-05-14 4 Brownlie Keith L SNGX Option (Right to Buy) M - Exercise D 0.30 -16,667 8,333
2014-05-16 2014-05-14 4 Brownlie Keith L SNGX Common Stock M - Exercise D 0.3000 16,667 5 35,714
2014-05-14 2014-05-13 4 SCHABER CHRISTOPHER J SNGX Option (Right to Buy) M - Exercise D 0.64 -7,815 112,185
2014-05-14 2014-05-13 4 SCHABER CHRISTOPHER J SNGX Common Stock M - Exercise D 0.6400 7,815 5 67,496
2014-01-08 2014-01-06 4 Straube Richard SNGX Stock Option (Right to Buy) A - Award D 2.01 100,000 100,000
2013-12-09 2013-12-05 4 BREY ROBERT N SNGX Stock Option (Right to Buy) A - Award D 2.01 10,000 10,000
2013-12-09 2013-12-05 4 Brughera Marco Maria SNGX Stock Option (Right to Buy) A - Award D 2.01 15,000 15,000
2013-12-09 2013-12-05 4 SCHABER CHRISTOPHER J SNGX Stock Option (Right to Buy) A - Award D 2.01 100,000 100,000
2013-12-09 2013-12-05 4 Warusz Joseph Michael SNGX Stock Option (Right to Buy) A - Award D 2.01 45,000 45,000
2013-10-01 2013-09-27 4 Brownlie Keith L SNGX Stock Option (Right to Buy) A - Award D 2.26 13,275 13,275
2013-10-01 2013-09-27 4 RUBIN ROBERT J. SNGX Stock Option (Right to Buy) A - Award D 2.26 13,275 13,275
2013-10-01 2013-09-27 4 ZELDIS JEROME B SNGX Stock Option (Right to Buy) A - Award D 2.26 13,275 13,275
2013-10-01 2013-09-27 4 LAPOINTE ANTHONY GREGG SNGX Stock Option (Right to Buy) A - Award D 2.26 13,275 13,275
2013-09-27 2013-09-25 4 BREY ROBERT N SNGX Stock Option (Right to Buy) A - Award D 0.68 35,000 35,000
2013-09-27 2013-09-25 4 HORGAN KEVIN SNGX Stock Option (Right to Buy) A - Award D 0.68 85,000 85,000
2013-09-27 2013-09-25 4 SCHABER CHRISTOPHER J SNGX Stock Option (Right to Buy) A - Award D 0.68 130,000 130,000
2013-09-27 2013-09-25 4 Warusz Joseph Michael SNGX Stock Option (Right to Buy) A - Award D 0.68 55,000 55,000
2013-06-26 3 INTREXON CORP by Intrexon Corporation SNGX Common Stock I 1,034,483
2013-06-26 3 INTREXON CORP by NRM VII Holdings SNGX Common Stock I 3,333,333
2013-06-26 2013-06-25 4 Brownlie Keith L SNGX Common Stock Warrants P - Purchase D 1.65 14,286 14,285
2013-06-26 2013-06-25 4 Brownlie Keith L SNGX Common Stock P - Purchase D 1.0500 19,047 20 19,047
2013-06-26 2013-06-25 4 SCHABER CHRISTOPHER J SNGX Common Stock Warrants P - Purchase D 1.65 7,143 7,142
2013-06-26 2013-06-25 4 SCHABER CHRISTOPHER J SNGX Common Stock P - Purchase D 1.0500 9,523 10 59,681
2013-06-26 2013-06-25 4 ZELDIS JEROME B SNGX Common Stock Warrants P - Purchase D 1.65 17,857 17,857
2013-06-26 2013-06-25 4 ZELDIS JEROME B SNGX Common Stock P - Purchase D 1.0500 23,809 25 48,809
2013-06-24 2013-06-20 4 ZELDIS JEROME B SNGX Stock Option (Right to Buy) M - Exercise D 0.30 -25,000 0
2013-06-24 2013-06-20 4 ZELDIS JEROME B SNGX Common Stock M - Exercise D 0.3000 25,000 8 25,000
2012-12-21 2012-12-20 4 CAVAZZA PAOLO Indirect SNGX Common Stock Warrant (warrant to buy) J - Other I 0.53 1 1
2012-12-21 2012-12-20 4 CAVAZZA PAOLO Indirect SNGX Common Stock Warrant (warrant to buy) J - Other I 0.53 1 1
2012-12-21 2012-12-20 4 CAVAZZA PAOLO Indirect SNGX Common Stock Warrant (warrant to buy) J - Other I 5.60 -1 0
2012-12-21 2012-12-20 4 CAVAZZA PAOLO Indirect SNGX Common Stock Warrant (warrant to buy) J - Other I 5.60 -1 0
2012-12-21 2012-12-20 4 CAVAZZA PAOLO Indirect SNGX Common Stock Warrant (warrant to buy) J - Other I 5.60 -1 0
2012-12-21 2012-12-20 4 Essetifin SPA Indirect SNGX Common Stock Warrant (right to buy) J - Other I 0.53 1 1
2012-12-21 2012-12-20 4 Essetifin SPA Indirect SNGX Common Stock Warrant (right to buy) J - Other I 5.60 -1 0
2012-12-21 2012-12-20 4 Essetifin SPA Indirect SNGX Common Stock Warrant (right to buy) J - Other I 5.60 -1 0
2012-07-25 2012-06-21 4 Brownlie Keith L SNGX Stock Option (Right to Buy) A - Award D 0.30 25,000 25,000
2012-07-25 2012-06-21 4 LAPOINTE ANTHONY GREGG SNGX Stock Option (Right to Buy) A - Award D 0.30 25,000 25,000
2012-07-25 2012-06-21 4 RUBIN ROBERT J. SNGX Stock Option (Right to Buy) A - Award D 0.30 25,000 25,000
2012-07-25 2012-06-21 4 ZELDIS JEROME B SNGX Stock Option (Right to Buy) A - Award D 0.30 25,000 25,000
2012-04-11 2012-04-10 4 SCHABER CHRISTOPHER J SNGX Common Stock P - Purchase D 0.5098 9,900 5 50,157
2012-01-18 2012-01-16 4 SCHABER CHRISTOPHER J SNGX Common Stock A - Award D 333,333 805,150
2010-06-22 2010-06-18 4 RUBIN ROBERT J. SNGX Common Stock P - Purchase D 0.2050 243,902 50 243,902
2010-06-21 2010-06-18 4 Essetifin SPA Indirect SNGX Common Stock Warrant (right to buy) J - Other I 0.28 1 1
2010-06-21 2010-06-18 4 Essetifin SPA Indirect SNGX Common Stock P - Purchase I 0.2050 8,608,580 1,765 54,227,816
2009-09-28 2009-09-24 4 Essetifin SPA Indirect DORB Common Stock Warrant (right to buy) J - Other I 0.28 1 1
2009-09-28 2009-09-24 4 Essetifin SPA Indirect DORB Common Stock P - Purchase I 0.2530 3,952,569 1,000 45,619,236
2009-02-13 2009-02-11 4 Essetifin SPA Indirect DORB Common Stock P - Purchase I 0.1800 25,000,000 4,500 41,666,667
2008-12-03 3 Leadiant Biosciences, Inc. Indirect DORB Common Stock I 16,666,667
2007-07-02 3 Buhrman Cyrille F DORB Common Stock D 4,900,020
2007-07-02 2007-06-28 4 Buhrman Cyrille F DORB Stock Options (right to buy) A - Award D 0.33 150,000 150,000
2004-02-18 2004-02-13 4 ELAN CORP PLC I DOR Common Stock S - Sale I 1.0100 -875,300 -884 162,600
2004-02-18 2004-02-13 4 ELAN CORP PLC I DOR Common Stock S - Sale I 1.0200 -248,700 -254 1,037,900
2004-02-18 2004-02-13 4 ELAN CORP PLC I DOR Common Stock S - Sale I 1.0300 -68,200 -70 1,286,600
2004-02-18 2004-02-13 4 ELAN CORP PLC I DOR Common Stock S - Sale I 1.0400 -51,300 -53 1,354,800
2004-02-18 2004-02-13 4 ELAN CORP PLC I DOR Common Stock S - Sale I 1.0600 -12,600 -13 1,406,100
2004-02-18 2004-02-13 4 ELAN CORP PLC I DOR Common Stock S - Sale I 1.0700 -33,200 -36 1,418,700
2004-02-18 2004-02-13 4 ELAN CORP PLC I DOR Common Stock S - Sale I 1.0800 -17,000 -18 1,451,900
2004-02-13 2004-02-12 4 ELAN CORP PLC I DOR Common Stock S - Sale I 1.0100 -180,700 -183 1,468,900
2004-02-13 2004-02-12 4 ELAN CORP PLC I DOR Common Stock S - Sale I 1.0200 -5,600 -6 1,649,600
2004-02-13 2004-02-12 4 ELAN CORP PLC I DOR Common Stock S - Sale I 1.0500 -69,200 -73 1,655,200
2004-02-13 2004-02-12 4 ELAN CORP PLC I DOR Common Stock S - Sale I 1.0600 -11,000 -12 1,724,400
2004-02-13 2004-02-11 4 ELAN CORP PLC I DOR Common Stock S - Sale I 1.0500 -106,900 -112 1,735,400
2004-02-13 2004-02-11 4 ELAN CORP PLC I DOR Common Stock S - Sale I 1.0600 -44,900 -48 1,842,300
2004-02-13 2004-02-11 4 ELAN CORP PLC I DOR Common Stock S - Sale I 1.0700 -4,800 -5 1,887,200
2004-02-13 2004-02-11 4 ELAN CORP PLC I DOR Common Stock S - Sale I 1.0800 -16,600 -18 1,892,000
2004-02-13 2004-02-11 4 ELAN CORP PLC I DOR Common Stock S - Sale I 1.0900 -10,400 -11 1,908,600
2004-02-13 2004-02-11 4 ELAN CORP PLC I DOR Common Stock S - Sale I 1.1000 -81,000 -89 1,919,000
2004-02-13 2004-02-11 4 ELAN CORP PLC I DOR Common Stock S - Sale I 1.1100 -52,879 -59 2,000,000
2004-02-06 2004-02-04 4 ELAN CORP PLC I DOR Series B Convertible Preferred Stock J - Other I 5.11 126,567 126,567
2004-02-06 2002-12-12 4 ELAN CORP PLC I DOR Common Stock J - Other I 500,000 2,052,879
2004-02-06 2002-10-21 4 ELAN CORP PLC I DOR Series C Convertible Preferred Stock C - Conversion I 8.86 -110,323 0
2004-02-06 2002-10-21 4 ELAN CORP PLC I DOR Common Stock C - Conversion I 8.8600 1,245,187 11,032 1,552,879
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
Other Listings
DE:DOA
DE:DOA0
GB:0A6I
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista